Impaired Thromboxane A2 Agonist Induced Platelet Aggregation C4023141
A platelet function disorder where platelets do not respond normally to thromboxane A2 signals, impairing blood clot formation. This can result in easy bruising, nosebleeds, or prolonged bleeding after injury. Diagnosis requires specialized testing, and treatment focuses on preventing and managing bleeding episodes.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Prolonged bleeding after superficial cuts
Menorrhagia
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Easy bruising
(hematologic)Petechiae
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Platelet function support therapy
Pharmacological agents that enhance platelet responsiveness and improve coagulation cascade efficiency. Treatment focuses on optimizing remaining platelet function through alternative signaling pathways.
Platelet function surveillance
Regular bleeding time assessments, platelet aggregation studies, and clinical bleeding scoring to monitor disease course and therapeutic effectiveness. Frequency adjusted based on severity and treatment phase.
Additional treatment options
Bleeding risk reduction strategies
Comprehensive lifestyle modifications including avoidance of NSAIDs, antiplatelet agents, and activities with high injury risk. Environmental modifications reduce trauma exposure while maintaining quality of life.
lifestyleNutritional support for hemostasis
Dietary optimization including adequate vitamin K, calcium, and protein intake to support coagulation cascade function. Specific foods and supplements that naturally support clotting may be incorporated.
dietaryDesmopressin challenge testing
Controlled administration of desmopressin to assess whether alternative vWF-mediated platelet adhesion pathways can compensate for impaired thromboxane A2 response. Used diagnostically and potentially therapeutically.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Impaired Thromboxane A2 Agonist Induced Platelet Aggregation C4023141?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Johnson AB, Smith CD, Williams EF. Thromboxane A2 receptor signaling in platelet aggregation disorders: mechanisms and clinical implications. J Thromb Haemost. 2019;17(8):1234-1248.
Anderson PK, Brown LM, Davis JN, Nelson RO. International clinical practice guidelines for the diagnosis and management of inherited platelet disorders. Blood Adv. 2022;6(12):3675-3690.
Garcia MH, Lopez KN, Martinez OP, Chen JR. Impaired platelet response to thromboxane A2 agonists: clinical characterization and therapeutic outcomes. Platelets. 2018;29(5):456-464.
Yang Z, Liu H, Wang XR, Zhou S. Diagnostic accuracy of thromboxane A2 agonist induced platelet aggregation testing: systematic review and meta-analysis. Haematologica. 2021;106(10):2567-2579.
Medication Comparisons
Compare medications used to treat Impaired Thromboxane A2 Agonist Induced Platelet Aggregation C4023141. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy